Evidence map›Paper›PMID 40971588›Full record

ArticleTechnology in cancer research & treatment

The Bharat Cancer Genome Atlas: Charting India's Unique Cancer Landscape for Precision Oncology.

Sundarasamy Mahalingam, Vinod Scaria, Sridhar Sivasubbu

Abstract readEditorial
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sundarasamy MahalingamDepartment of Biotechnology, National Cancer Tissue Biobank, Indian Institute of Technology-Madras, Chennai, Tamil Nadu, India.ORCID 0000-0003-4460-3949
Vinod ScariaKarkinos Healthcare Pvt. Ltd., Turbhe, Navi Mumbai, Maharashtra, India.
Sridhar SivasubbuKarkinos Healthcare Pvt. Ltd., Turbhe, Navi Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of the Bharat Cancer Genome Atlas (BCGA) is poised to be a comprehensive genomic database which will not only deepen our scientific understanding of the unique molecular landscape of cancers prevalent in India but also provide the essential foundation required to facilitate the development of targeted therapies, enable personalized treatment strategies, and foster the creation of more effective early detection methods specifically tailored for the Indian population. The open-access nature of the BCGA is a core strength, designed to democratize access to this vital information, thereby empowering researchers to make new discoveries, enabling clinicians to provide more precise care, and allowing patients and their families to engage more fully in their health journey.

Indexed as

Genome, HumanGenomicsNeoplasmsPrecision MedicineBiomarkers, TumorDatabases, GeneticHumansIndiaMedical OncologyBiomarkers, TumorBGCAbreast cancergenomics

Identifiers

PMID40971588
PMCPMC12449626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.